News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Strikes Pact To Market Novartis AG (NVS)'s Respiratory Inhalers In The UK



9/5/2014 6:42:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

UK chronic obstructive pulmonary disease patients will be cheered by the news that Pfizer has signed a deal to promote two new drugs developed by Novartis.

The therapies in question are Seebri (glycopyrronium) and Ultibro (indacaterol/glycopyrronium) delivered through Novartis’ Breezhaler device. While the former has been available in the UK market since November 2012, Ultibro, which has a European licence, has not yet been launched.

Hey, check out all the research scientist jobs. Post your resume today!



comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES